Board Change • May 20
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Hetalben Patel was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • May 13
Lead Reclaim and Rubber Products Limited to Report Second Half, 2026 Results on May 15, 2026 Lead Reclaim and Rubber Products Limited announced that they will report second half, 2026 results on May 15, 2026 Board Change • Feb 25
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Hetalben Patel was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Board Change • Feb 05
Less than half of directors are independent No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 2 experienced directors. 3 highly experienced directors. 2 independent directors (3 non-independent directors). Independent Director Hetalben Patel was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment. Announcement • Nov 14
Lead Reclaim and Rubber Products Limited to Report First Half, 2026 Results on Nov 14, 2025 Lead Reclaim and Rubber Products Limited announced that they will report first half, 2026 results on Nov 14, 2025 Announcement • Sep 08
Lead Reclaim and Rubber Products Limited, Annual General Meeting, Sep 30, 2025 Lead Reclaim and Rubber Products Limited, Annual General Meeting, Sep 30, 2025, at 11:00 Indian Standard Time. Location: 856/4, sarali pithai road pithai, pithai kathlal kheda gj-387630, India New Risk • Aug 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (11% operating cash flow to total debt). Market cap is less than US$10m (₹609.7m market cap, or US$7.00m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Share price has been volatile over the past 3 months (6.7% average weekly change). Profit margins are more than 30% lower than last year (3.8% net profit margin). Revenue is less than US$5m (₹190m revenue, or US$2.2m). Valuation Update With 7 Day Price Move • Jun 06
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹70.00, the stock trades at a trailing P/E ratio of 71.4x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 113% over the past year. New Risk • May 30
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2024. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (11% operating cash flow to total debt). Market cap is less than US$10m (₹444.2m market cap, or US$5.20m). Minor Risks Latest financial reports are more than 6 months old (reported September 2024 fiscal period end). Profit margins are more than 30% lower than last year (3.8% net profit margin). Revenue is less than US$5m (₹190m revenue, or US$2.2m). Valuation Update With 7 Day Price Move • Apr 16
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹60.15, the stock trades at a trailing P/E ratio of 61.3x. Average trailing P/E is 25x in the Chemicals industry in India. Total returns to shareholders of 82% over the past year. Valuation Update With 7 Day Price Move • Mar 04
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₹56.50, the stock trades at a trailing P/E ratio of 57.6x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 48% over the past year. New Risk • Sep 21
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.4% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.4% average weekly change). Market cap is less than US$10m (₹784.8m market cap, or US$9.40m). Minor Risks Profit margins are more than 30% lower than last year (2.5% net profit margin). Revenue is less than US$5m (₹148m revenue, or US$1.8m). Board Change • Sep 11
Less than half of directors are independent Following the recent departure of a director, there are only 2 independent directors on the board. The company's board is composed of: 2 independent directors. 3 non-independent directors. Independent Director Hetalben Patel was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Jul 26
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹37.50, the stock trades at a trailing P/E ratio of 74.4x. Average trailing P/E is 35x in the Chemicals industry in India. Total loss to shareholders of 30% over the past year. Valuation Update With 7 Day Price Move • Jul 12
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹38.75, the stock trades at a trailing P/E ratio of 76.9x. Average trailing P/E is 35x in the Chemicals industry in India. Total loss to shareholders of 32% over the past year. New Risk • Jun 15
New minor risk - Profit margin trend The company's profit margins are lower than last year and have reduced by more than 30%. Net profit margin: 2.5% Last year net profit margin: 9.5% This is considered a minor risk. A large drop in profit margin could indicate the company does not have strong competitive advantages or it is yet to establish itself and its core business. Even if it is a well established business, this may make it a much riskier investment than one that has a combination of proven competitive advantages and a stable or growing profit margin. Currently, the following risks have been identified for the company: Major Risk Market cap is less than US$10m (₹235.7m market cap, or US$2.82m). Minor Risks Share price has been volatile over the past 3 months (8.7% average weekly change). Profit margins are more than 30% lower than last year (2.5% net profit margin). Revenue is less than US$5m (₹149m revenue, or US$1.8m). New Risk • May 28
New minor risk - Financial data availability The company's latest financial reports are more than 6 months old. Last reported fiscal period ended September 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.9% average weekly change). High level of non-cash earnings (42% accrual ratio). Market cap is less than US$10m (₹249.6m market cap, or US$3.00m). Minor Risks Latest financial reports are more than 6 months old (reported September 2023 fiscal period end). Revenue is less than US$5m (₹90m revenue, or US$1.1m). Valuation Update With 7 Day Price Move • May 24
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹35.35, the stock trades at a trailing P/E ratio of 49.2x. Average trailing P/E is 31x in the Chemicals industry in India. Total loss to shareholders of 50% over the past year. New Risk • Feb 09
New major risk - Share price stability The company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of Indian stocks, typically moving 9.6% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.6% average weekly change). High level of non-cash earnings (42% accrual ratio). Market cap is less than US$10m (₹292.2m market cap, or US$3.52m). Minor Risk Revenue is less than US$5m (₹90m revenue, or US$1.1m). Valuation Update With 7 Day Price Move • Feb 07
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹36.55, the stock trades at a trailing P/E ratio of 50.9x. Average trailing P/E is 31x in the Chemicals industry in India. Valuation Update With 7 Day Price Move • Dec 08
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to ₹34.20, the stock trades at a trailing P/E ratio of 47.6x. Average trailing P/E is 29x in the Chemicals industry in India. Reported Earnings • Nov 15
First half 2024 earnings released: EPS: ₹0.17 (vs ₹1.22 in 1H 2023) First half 2024 results: EPS: ₹0.17 (down from ₹1.22 in 1H 2023). Revenue: ₹50.7m (up 28% from 1H 2023). Net income: ₹1.40m (down 70% from 1H 2023). Profit margin: 2.8% (down from 12% in 1H 2023). The decrease in margin was driven by higher expenses. Valuation Update With 7 Day Price Move • Sep 29
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹50.85, the stock trades at a trailing P/E ratio of 45.1x. Average trailing P/E is 27x in the Chemicals industry in India. Recent Insider Transactions • Sep 28
Managing Director recently bought ₹274k worth of stock On the 26th of September, Jayeshkumar Patel bought around 6k shares on-market at roughly ₹45.64 per share. This transaction amounted to less than 1% of their direct individual holding at the time of the trade. This was the largest purchase by an insider in the last 3 months. This was Jayeshkumar's only on-market trade for the last 12 months. New Risk • Jun 15
New major risk - Revenue and earnings growth Revenue has declined by 14% over the past year. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If revenues are declining, then it is difficult for the company to prevent its earnings from declining as well. A trend of falling revenue can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Revenue has declined by 14% over the past year. High level of non-cash earnings (44% accrual ratio). Market cap is less than US$10m (₹454.1m market cap, or US$5.52m). Minor Risk Revenue is less than US$5m (₹90m revenue, or US$1.1m). Announcement • Jun 01
Lead Reclaim and Rubber Products Limited to Report Second Half, 2023 Results on May 30, 2023 Lead Reclaim and Rubber Products Limited announced that they will report second half, 2023 results on May 30, 2023 Valuation Update With 7 Day Price Move • May 08
Investor sentiment improves as stock rises 18% After last week's 18% share price gain to ₹42.70, the stock trades at a trailing P/E ratio of 65.5x. Average trailing P/E is 21x in the Chemicals industry in India. Valuation Update With 7 Day Price Move • Apr 06
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹35.60, the stock trades at a trailing P/E ratio of 54.6x. Average trailing P/E is 19x in the Chemicals industry in India. Valuation Update With 7 Day Price Move • Mar 08
Investor sentiment improves as stock rises 38% After last week's 38% share price gain to ₹38.15, the stock trades at a trailing P/E ratio of 58.5x. Average trailing P/E is 20x in the Chemicals industry in India. 